Understanding how DNA replication starts in cells
Mechanisms of replication origin licensing studied by real-time single-molecule fluorescence
This study is looking at how DNA starts to copy itself, which is really important for healthy cell division, and it's using special technology to watch this process happen in real time, so we can learn more about how mistakes in DNA copying might lead to cancer and other health issues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10912563 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind the initiation of DNA replication, which is crucial for cell division and maintaining genetic integrity. By using advanced single-molecule fluorescence microscopy, the study aims to observe the loading of helicase proteins onto DNA in real time, allowing for a detailed understanding of the biochemical events involved. This approach helps to overcome limitations of traditional methods that do not capture the dynamic nature of these processes. Insights gained from this research could lead to better understanding of cancer and developmental disorders linked to DNA replication errors.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic predispositions to cancers or developmental abnormalities related to DNA replication.
Not a fit: Patients with conditions unrelated to DNA replication or those who do not have a genetic component to their disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic targets for treating cancers and genetic disorders caused by DNA replication failures.
How similar studies have performed: Previous research using single-molecule techniques has shown promise in understanding complex biological processes, indicating that this approach could yield valuable insights.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Bell, Stephen P. — Massachusetts Institute of Technology
- Study coordinator: Bell, Stephen P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.